Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Congy

Showing results (111-120 of 150) with videos related to

Pageof 15
Sort By:
Clinical Immunology (Orlando, Fla.)|June 26, 2017
Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumabBénédicte Puissant-Lubrano, Sylvain Puissochet, Nicolas Congy-Jolivet, et al.
Medicina (Kaunas, Lithuania)|July 29, 2023
Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes ChildrenChloé Girard, Aurélie De Percin, Carole Morin, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1992
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonistM Rinaldi-Carmona, C Congy, V Santucci, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 18, 2015
Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremiaJulie Belliere, Nassim Kamar, Catherine Mengelle, et al.
Annales De Medecine Interne|January 1, 1989
[AIDS in elderly patients. Apropos of 22 cases observed in the Paris region]Q Nguyen, M Laurent, J P Bouchon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2020
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?Maéva Massat, Nicolas Congy-Jolivet, Anne-Laure Hebral, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 22, 2016
Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-HLA AntibodiesI Ferrandiz, N Congy-Jolivet, A Del Bello, et al.
Journal of Autoimmunity|September 17, 2022
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseasesYves Renaudineau, Laurent Sailler, Florence Abravanel, et al.
Clinical Transplantation|April 30, 2013
Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimenNassim Kamar, Arnaud Del Bello, Nicolas Congy-Jolivet, et al.
European Journal of Pharmacology|June 15, 1993
Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonistM Rinaldi-Carmona, M Bouaboula, C Congy, et al.
Pageof 15

Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Clinical Immunology (Orlando, Fla.)|June 26, 2017
Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumabBénédicte Puissant-Lubrano, Sylvain Puissochet, Nicolas Congy-Jolivet, et al.
Medicina (Kaunas, Lithuania)|July 29, 2023
Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes ChildrenChloé Girard, Aurélie De Percin, Carole Morin, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1992
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonistM Rinaldi-Carmona, C Congy, V Santucci, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 18, 2015
Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremiaJulie Belliere, Nassim Kamar, Catherine Mengelle, et al.
Annales De Medecine Interne|January 1, 1989
[AIDS in elderly patients. Apropos of 22 cases observed in the Paris region]Q Nguyen, M Laurent, J P Bouchon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 3, 2020
Do anti-IL-6R blockers have a beneficial effect in the treatment of antibody-mediated rejection resistant to standard therapy after kidney transplantation?Maéva Massat, Nicolas Congy-Jolivet, Anne-Laure Hebral, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 22, 2016
Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-HLA AntibodiesI Ferrandiz, N Congy-Jolivet, A Del Bello, et al.
Journal of Autoimmunity|September 17, 2022
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseasesYves Renaudineau, Laurent Sailler, Florence Abravanel, et al.
Clinical Transplantation|April 30, 2013
Incidence of donor-specific antibodies in kidney transplant patients following conversion to an everolimus-based calcineurin inhibitor-free regimenNassim Kamar, Arnaud Del Bello, Nicolas Congy-Jolivet, et al.
European Journal of Pharmacology|June 15, 1993
Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonistM Rinaldi-Carmona, M Bouaboula, C Congy, et al.
Pageof 15